National Health (Pharmaceutical Benefits) Regulations (Amendment)

STATUTORY RULES.

1963. No. 34

_______

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1962.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1962.

Dated this twenty-first

day of  April, 1963.

DE L ‘ISLE

Governor-General.

By His Excellency’s Command,

Minister of State for Health.

_________

Amendments of the National Health (Pharmaceutical Benefits) Regulations.†

Commencement.

1.  These Regulations shall come into operation on the first day of May, 1963.

First Schedule.

2.  The First Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by inserting after the words—

“ Hexamethonium Tartrate.”

the words—

“ Hexamethonium Tartrate Injection.”;

(b) by omitting the words—

“ Pyrimethamine Tablets.”;

and

(c) by omitting the words—

“ Suxamethonium Chloride Injection.”.

_______________________________________________________________________________________

* Notified in the Commonwealth Gazette on 26th April, 1963.

† Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos 59 and 137; and 1962, Nos. 34, 101 and 114.

2813/63.—Price 5d.  10/8.4.1963.

Second Schedule.

3.  The Second Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by adding at the end of the second column of the item relating to the pharmaceutical benefit “Chloramphenicol B.P.” the words—

“ Chloramphenicol B.P. with Polymyxin B. Sulphate B.P.”;

(b) by inserting after the item relating to the pharmaceutical benefit “ Cortisone Acetate B.P.” the following item:—

(c) by adding at the end of the second column of the item relating to the pharmaceutical benefit “ Ergotamine Tartrate B.P.” the words—

“ Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride ”;

 and

(d) by adding at the end of the item relating to the pharmaceutical benefit “ Polymyxin B. Sulphate B.P.” the words—

“ Polymyxin B. Sulphate B.P. with Chloramphenicol B.P.”.

Third Schedule.

4.  The Third Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by inserting after the words—

“ Acetazolamide Sodium.”

the word—

“ Acetohexamide.”;

(b) by inserting after the word and letter—

“ Amphotericin B.”

the word—

“ Ampicillin.”;

(c) by inserting before the word—

“ Cyclopenthiazide.”

the words—

“ Cyclizine Hydrochloride.”;

(d) by omitting the words and letter—

“ Desacetyl Lanatoside, C.”

and inserting in their stead the word—

“ Deslanoside.”;

(e) by inserting after the words—

“ Diphtheria Toxoid Purified.”

the word—

“ Dipyridamole.”;

(f) by inserting after the word—

“ Hydroflumethiazide.”

the word—

“ Hydroxocobalamin.”;

(g) by inserting after the words and letters—

“ Levorphanol Tartrate, B.P.C.”

the word—

“ Liothyronine.”;

(h) by inserting after the words—

“ Mecholyl Chloride.”

the words—

“ Medroxyprogesterone Acetate.”;

(i) by inserting before the word—

“ Methazolamide.”

the words—

“ Metaraminol.

Metformin.”;

(j) by inserting after the word—

“ Methotrexate.”

the words and letters—

“ Methoxamine Hydrochloride, B.P.C.”;

(k) by inserting after the words and letters—

“ Methylcellulose Mucilage, A.P.F.”

the word—

“ Methyldopa.”;

(l) by inserting after the word—

“ Nandrolone.”

the word—

“ Niclosamide.”;

(m) by inserting after the word—

“ Polydimethylsiloxanes.”

the word—

“ Polythiazide.”;

(n) by omitting the word—

“ Pyrimido-Prymidine.”;

(o) by inserting after the words—

“ Tripolidine Hydrochloride.”

the word—

“ Vadrine”;

and

(p) by inserting before the word—

“ Veriloid.”

the word—

“ Velactin.”.

Fifth Schedule.

5.  The Fifth Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by inserting after the item relating to the pharmaceutical benefit “ Amphotericin B.” the following item:—

(b) by omitting the item relating to the pharmaceutical benefit “ Calciferol Tablets B.P.” and inserting in its stead the following item:—

(c) by inserting after the item relating to the pharmaceutical benefit “ Diiodohydroxyquinoline B.P., Vaginal Tablet ” the following item:—

(d) by inserting after the item relating to the pharmaceutical benefit “ Diphenhydramine Hydrochloride B.P., Elixir ” the following item:—

(e) by inserting after the item relating to the pharmaceutical benefit “ Hydrocortisone Sodium Succinate Injection B.P.” the following items:—

(f) by inserting after the item relating to the pharmaceutical benefit “ Levorphanol Tartrate B.P.C.” the following item:—

(g) by inserting before the item relating to the pharmaceutical benefit “ Mepyramine Maleate Elixir ” the following items: —

(h) by omitting the item relating to the pharmaceutical benefit “ Methyl Prednisolone Acetate ” and inserting in its stead the following item:—

(i) by omitting the item relating to the pharmaceutical benefit “ Polydimethylsiloxanes ” and inserting in its stead the following items:—

(j) By inserting after the item relating to the pharmaceutical benefit “ Pyridine Aldoxime Methiodide ” the following item:—

and

(k) by omitting the item relating to the pharmaceutical benefit “ Vancomycin Hydrochloride ” and inserting in its stead the following items:—

_____________________

By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra.